Treatment of Recurrent/Metastatic Head and Neck Cancer
Treatment of Recurrent/Metastatic Head and Neck Cancer
Not yet recruiting · NCT07601204 · Registry updated 2026-05-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Treatment of Recurrent/Metastatic Head and Neck Cancer | Head and Neck Neoplasms, Neoplasms by Site, neoplasm | Not yet recruiting | Phase 1 / Phase 2 | 2026-05-22 | NCT07601204 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. | 16 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Hospital Chinese Academy of Medical Sciences | Beijing | China | 71 |
| Guangxi Cancer InstituteGuangxi Cancer Hospital | Nanning | China | 1 |
| Hubei Cancer Hospital | Wuhan | China | 95 |
| Hunan Cancer Hospital | Changsha | China | 123 |
| Shanxi Cancer Hospital | Taiyuan | China | 24 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |
| The First Hospital of China Medical University | Shenyang | China | 43 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 20 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 7 |
| West China Medical Center,Sichuan Medical University | Chengdu | China | 1 |